YD Bio Ltd (YDES) — Institutional Holders, Q2 2026
19 institutional investment managers reported a YDES position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.5M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
YDES in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Garrett Wealth Advisory GroupNew · +84,630 sh+$190.4K
- JANE STREET GROUPNew · +21,423 sh+$48.2K
- SkyView Investment AdvisorsNew · +1,777 sh+$4.0K
- WELLS FARGO & COMPANYNew · +75 sh+$169.00
Biggest sellers
- SUMMIT SECURITIES GROUPSold out · -1 sh-$2.00
YDES 13F holders ranked 1–19 of 19
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Cypress Capital Management (WY)#1 · 4,678,142 sh | 4,678,142 | $1.5M | 1.27% | +1.2% |
| 2 | Oasis Management Ltd.#2 · 100,000 sh | 100,000 | $225.0K | 0.01% | 0.0% |
| 3 | Garrett Wealth Advisory Group#3 · 84,630 sh | 84,630 | $190.4K | — | New |
| 4 | Cerity Partners#4 · 352,495 sh | 352,495 | $172.1K | <0.01% | 0.0% |
| 5 | GEODE CAPITAL MANAGEMENT#5 · 62,714 sh | 62,714 | $141.1K | 0.00% | +4.1% |
| 6 | True North Advisors#6 · 220,819 sh | 220,819 | $68.5K | — | 0.0% |
| 7 | CITADEL ADVISORS#7 · 30,106 sh | 30,106 | $67.7K | 0.00% | +54.8% |
| 8 | JANE STREET GROUP#8 · 21,423 sh | 21,423 | $48.2K | 0.00% | New |
| 9 | Clear Street Group#9 · 102,358 sh | 102,358 | $31.7K | <0.01% | 0.0% |
| 10 | UBS Group AG#10 · 12,384 sh | 12,384 | $27.9K | 0.00% | +6.5% |
| 11 | ARISTEIA CAPITAL, L.L.C.#11 · 63,274 sh | 63,274 | $16.6K | <0.01% | 0.0% |
| 12 | WOLVERINE ASSET MANAGEMENT#12 · 4,886 sh | 4,886 | $11.0K | <0.01% | 0.0% |
| 13 | Merit Financial Group#13 · 19,239 sh | 19,239 | $6.0K | 0.00% | -51.9% |
| 14 | Concurrent Investment Advisors#14 · 17,672 sh | 17,672 | $5.5K | — | 0.0% |
| 15 | SkyView Investment Advisors#15 · 1,777 sh | 1,777 | $4.0K | <0.01% | New |
| 16 | MORGAN STANLEY#16 · 160 sh | 160 | $360.00 | 0.00% | -28.3% |
| 17 | WELLS FARGO & COMPANY#17 · 75 sh | 75 | $169.00 | 0.00% | New |
| 18 | FMR#18 · 1 sh | 1 | $2.00 | 0.00% | 0.0% |
| 19 | ROYAL BANK OF CANADA#19 · 117 sh | 117 | $0.00 | 0.00% | New |
Funds that sold out of YDES in Q2 2026 (1)
Held YDES at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| SUMMIT SECURITIES GROUP1 sh | 1 | $1.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.